Antonis Valachis

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, Weixiu Luo, Per Karlsson et al. · The Lancet Oncology · 2017 · 120 citations

Breast Oncology, Medicine, Cancer Management +7

Incidence, Clinical, Microbiological Features and Outcome of Bloodstream Infections in Patients Undergoing Hemodialysis

Maria Fysaraki, George Samonis, Antonis Valachis et al. · International Journal of Medical Sciences · 2013 · 92 citations · Full text

Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: A case–case-control study

Diamantis P. Kofteridis, Antonis Valachis, Dimitra Dimopoulou et al. · Journal of Infection and Chemotherapy · 2014 · 63 citations

Health Sciences, Antibiotics, Medicine +13

Predisposing factors, clinical characteristics and outcome of Pneumonocystis jirovecii pneumonia in HIV-negative patients

Diamantis P. Kofteridis, Antonis Valachis, Maria Velegraki et al. · Journal of Infection and Chemotherapy · 2014 · 61 citations

Pneumonocystis Jirovecii Pneumonia, Clinical Characteristics, Klebsiella Pneumoniae +7

Treatment pattern, prognostic factors, and outcome in patients with infection due to pan-drug-resistant gram-negative bacteria

Diamantis P. Kofteridis, Angeliki M. Andrianaki, Sofia Maraki et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2020 · 45 citations

Pan-drug-resistant Gram-negative Bacteria, Treatment Pattern, Prognostic Factors +10